SCHEMBL24675067

SCHEMBL24675067

CN1CCN2c3ncc(C(C)(C)C)cc3N(CC3CC3)C(=S)[C@@H]2C1

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CYP2D6 P10635 1/20 0.31
CHRM1 P11229 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
DRD1 P21728 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTR7 P34969 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
HTR2B P41595 1/20 0.31
HTR3A P46098 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675031 0.88 PIK3CA (0.35) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675072 0.86 CYP1A2 (0.32) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675022 0.80 ALDH1A1 (0.34) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675034 0.80 ALDH1A1 (0.34) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675038 0.77 VRK1 (0.36) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675040 0.76 TIPARP (0.40) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675057 0.75
SCHEMBL24675049 0.75 KDM4E (0.32)
SCHEMBL24675046 0.73 PIK3CA (0.36) CYP1A2CHRM2HTR1AADRA2ACYP2D6
SCHEMBL24675048 0.73 PIK3CA (0.36) CYP1A2CHRM2HTR1AADRA2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022223022-A1 FUSED-RING HETEROCYCLE DERIVATIVE AND MEDICAL APPLICATION THEREOF 四川海思科制药有限公司 2022-10-27 WO disclosed